1.5149
0.33%
0.0049
Schlusskurs vom Vortag:
$1.51
Offen:
$1.53
24-Stunden-Volumen:
37,639
Relative Volume:
0.11
Marktkapitalisierung:
$77.79M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-68.96M
KGV:
-0.9294
EPS:
-1.63
Netto-Cashflow:
$-56.62M
1W Leistung:
-0.33%
1M Leistung:
-5.90%
6M Leistung:
-13.92%
1J Leistung:
-77.42%
Pmv Pharmaceuticals Inc Stock (PMVP) Company Profile
Firmenname
Pmv Pharmaceuticals Inc
Sektor
Branche
Telefon
(609) 642-6664
Adresse
ONE RESEARCH WAY, PRINCETON
Pmv Pharmaceuticals Inc Stock (PMVP) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2022-03-02 | Hochstufung | Oppenheimer | Perform → Outperform |
2021-09-22 | Hochstufung | Goldman | Neutral → Buy |
2021-08-19 | Eingeleitet | Oppenheimer | Perform |
2021-08-02 | Eingeleitet | Guggenheim | Buy |
2021-07-29 | Eingeleitet | H.C. Wainwright | Buy |
2020-10-20 | Eingeleitet | BofA Securities | Buy |
2020-10-20 | Eingeleitet | Cowen | Outperform |
2020-10-20 | Eingeleitet | Evercore ISI | Outperform |
2020-10-20 | Eingeleitet | Goldman | Neutral |
Alle ansehen
Pmv Pharmaceuticals Inc Aktie (PMVP) Neueste Nachrichten
PMV Pharmaceuticals executive sells over $10k in company stock By Investing.com - Investing.com Canada
PMV Pharmaceuticals CFO sells over $4,300 in company stock By Investing.com - Investing.com Canada
PMV Pharmaceuticals executive sells over $10k in company stock - Investing.com India
PMV Pharmaceuticals executive sells over $10k in company stock By Investing.com - Investing.com Australia
Insider Selling: PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Insider Sells 7,218 Shares of Stock - MarketBeat
PMV Pharmaceuticals CFO sells over $4,300 in company stock - Investing.com India
PMV Pharmaceuticals executive sells over $10k in company stock By Investing.com - Investing.com UK
Closing Figures: PMV Pharmaceuticals Inc (PMVP)’s Negative Finish at 1.58, Down -1.25 - The Dwinnex
Assenagon Asset Management S.A. Has $401,000 Holdings in BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) - Defense World
Envestnet Portfolio Solutions Inc. Buys 5,351 Shares of MBIA Inc. (NYSE:MBI) - Defense World
Assenagon Asset Management S.A. Boosts Stake in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - MarketBeat
PMV Pharmaceuticals, Inc. to Post Q3 2024 Earnings of ($0.35) Per Share, HC Wainwright Forecasts (NASDAQ:PMVP) - MarketBeat
PMV Pharmaceuticals' (PMVP) Buy Rating Reaffirmed at HC Wainwright - MarketBeat
Corbus Pharmaceuticals Holdings Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits - Quantisnow
Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung - StockTitan
Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung - GlobeNewswire
PMVP (PMV Pharmaceuticals) EPS (Basic) : $-0.97 (TTM As of Jun. 2024) - GuruFocus.com
PMVP (PMV Pharmaceuticals) Purchase Of Investment : $-162.36 Mil (TTM As of Jun. 2024) - GuruFocus.com
PMVP (PMV Pharmaceuticals) GF Value Rank : 0 (As of Aug. 19, 2024) - GuruFocus.com
PMVP (PMV Pharmaceuticals) EV-to-Revenue : (As of Aug. 19, 2024) - GuruFocus.com
Vanguard Group Inc. Purchases 46,804 Shares of PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
Wharton San Diego Presents: The Future of Biotechnology in San Diego - Procopio
Panasonic (OTCMKTS:PCRFY) Stock Price Crosses Below Fifty Day Moving Average of $9.36 - Defense World
PMV Pharmaceuticals Initiates Strategic Lease Termination - TipRanks
PMV Pharmaceuticals Reports Second Quarter 2024 Financial - GlobeNewswire
PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial - StockTitan
Public Employees Retirement System of Ohio Raises Stock Position in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
Is PMV Pharmaceuticals (NASDAQ:PMVP) In A Good Position To Deliver On Growth Plans? - Simply Wall St
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Bought by Jacobs Levy Equity Management Inc. - MarketBeat
IMNN-01 Plus Perioperative Chemo Improves OS in Newly Diagnosed, Advanced Ovarian Cancer - OncLive
Acadian Asset Management LLC Increases Holdings in PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) Shares Purchased by Acadian Asset Management LLC - MarketBeat
Mirae Asset Global Investments Co. Ltd. Acquires Shares of 15,492 PMV Pharmaceuticals, Inc. (NASDAQ:PMVP) - Defense World
BNP Paribas Financial Markets Has $597,000 Holdings in UroGen Pharma Ltd. (NASDAQ:URGN) - Defense World
Mirae Asset Global Investments Co. Ltd. Buys New Stake in Atea Pharmaceuticals, Inc. (NASDAQ:AVIR) - Defense World
Rezatapopt Takes Aim at Previously Untargetable p53 Allele to Treat Advanced Solid Tumors - OncLive
PMV Pharmaceuticals (NASDAQ:PMVP) Trading Down 0.6% - Defense World
PMV Pharmaceuticals (NASDAQ:PMVP) Shares Down 0.6% - MarketBeat
PMV Pharmaceuticals Inc (PMVP)’s stock chart: A technical perspective - US Post News
A look into PMV Pharmaceuticals Inc (PMVP)’s deeper side - SETE News
FDA Approves Tepylute for Breast and Ovarian Cancer Treatment - OncLive
Biopharma Layoff Tracker 2024: Ginkgo, Cara, Barinthus and More Cut Staff - BioSpace
PMV Pharmaceuticals Inc Inc. (PMVP) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
PMV Pharmaceuticals Inc (PMVP) shows promising results - US Post News
Views of Wall Street's Leading Experts on PMV Pharmaceuticals Inc – Sete News - SETE News
Quarterly Snapshot: Quick and Current Ratios for PMV Pharmaceuticals Inc (PMVP) – DWinneX - The Dwinnex
PMV Pharmaceuticals Inc (PMVP) presents a great opportunity, but the stock is slightly overvalued – US Post News - US Post News
AFT Pharmaceuticals Limited (AFP) to Issue Final Dividend of $0.01 on July 3rd - Defense World
Here's Why PMV Pharmaceuticals (PMVP) Could be Great Choice for a Bottom Fisher - Yahoo News Malaysia
PMV Pharmaceuticals Inc (PMVP) may enjoy gains as insiders got busy in the recent days – Knox Daily - Knox Daily
Here's Why You Should Consider Buying Bioventus (BVS) Stock - Yahoo Canada Finance
Finanzdaten der Pmv Pharmaceuticals Inc-Aktie (PMVP)
Umsatz
Nettogewinn
Free Cashflow
ENV
Pmv Pharmaceuticals Inc-Aktie (PMVP) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Carulli Michael | Chief Financial Officer |
Sep 11 '24 |
Sale |
1.50 |
2,891 |
4,347 |
88,395 |
ORBIMED ADVISORS LLC | 10% Owner |
Nov 22 '23 |
Sale |
2.23 |
87,786 |
195,763 |
0 |
Mack David Henry | President and CEO |
Oct 18 '23 |
Option Exercise |
0.53 |
198,407 |
105,156 |
363,877 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Kapitalisierung:
|
Volumen (24h):